Domestic Economic Forecast – Federal Reserve Bank

Join HBS NEO for a discussion on “Domestic Economic Forecast + Program for Economic Inclusion” with Emily Garr Pacetti and Guhan Venkatu.

About the presenters…

Emily Garr Pacetti is a vice president and community affairs officer in the Community Development Department at the Federal Reserve Bank of Cleveland. She oversees the department, including research, policy analysis, and community outreach in the Cleveland Fed’s Fourth Federal Reserve District. Ms. Pacetti joined the Bank in July 2017. Prior to her current position, Garr Pacetti was associate director at The Rockefeller Foundation, director of research and evaluation at the Cleveland–based Fund for Our Economic Future and was a Fulbright Fellow in Mexico City (2005–2007). Garr Pacetti holds a BA in political communications from Emerson College, an MS in urban studies from el Colegio de México, and an MPA from the John F. Kennedy School of Government at Harvard University.

Guhan Venkatu is Group Vice President of the Research Department at the Federal Reserve Bank of Cleveland leads the department’s regional analysis and outreach group. He joined the Bank in 1998 as a research analyst. In his tenure with the Bank, he has held positions of increasing responsibility including economist and vice president and senior regional officer of the Bank’s Pittsburgh Branch. His prior research has focused on inflation and inflation expectations, housing and household finance, and factors related to regional economic growth. His research and analysis have been a re-source for the public, and the Bank’s president and boards of directors.

A Conversation with Fred Brown, MBA‘85: VACCINES Covid19

Join HBS NEO for a conversation with Fred Brown, MBA‘85, Medicinal Biochemist

BACK BY POPULAR DEMAND — Reprise of 9/30/20

Fellow HBS alum Fred Brown, MBA ’85, is a medicinal biochemist who has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic and 6 vaccine products. Collectively, these products save the lives of over 5.6 million people annually and generated over $35B of revenue in 2020.

Fred will provide insight into the latest developments with COVID vaccines including the Pfizer/BioNTech, Moderna/NIH, and AstraZeneca/University of Oxford vaccines. Fred has in-depth experience with vaccines, having led the vaccine development effort at Roche, and from his involvement in the development and launch of over a dozen vaccines worldwide.

Based on his review of the vaccine data, he will share his inside knowledge of the logistics coordinated by Operation WARP speed, and his ongoing consultation with Governors across the country including our Governor DeWine. There is much to say — Fred will prioritize the most important information for 45 minutes with some time for questions. He has graciously agreed to remain available afterward to provide additional detail, and have additional discussion and interaction following the scheduled time.

Please join us for this informative discussion where Fred will separate fact from myth, offer insider insights, and express hopefulness while offering appropriate warnings/caveats.

HBS Club of NEO Leadership Award 2020: Jack H. Schron

Each year HBS NEO awards the HBS Club of Northeast Ohio Leadership Award. Please plan to join us as we present the 2020 HBS Club of NEO Leadership Award to Jack H. Schron.  Dan T. Moore will conduct an interview Jack.

Award Criteria: A organization leader who is or has been a CEO or chairman of a public, private, or nonprofit organization. Success as a leader in NE Ohio measured by the impact that the leader’s activities will have on the future of NE Ohio. Leadership in fulfilling the responsibilities of a successful organization to its employees, to the community and to society as measured by how these activities will impact the future of northeast Ohio.

About Jack Schron, 2020 Recipient of the Leadership Award

  • Leadership in public service—member of the Cuyahoga County Council
  • Leadership in education— founder of Tooling University

Holiday Cheer with Yule Tide Offerings

It is purely social!

RSVP before 11/30/20 and we will deliver to your home a six-pack of the holiday offerings from PLATFORM BEER CO.

Conversation with Tom Mihaljevic, CEO, Cleveland Clinic

Join HBS NEO for a conversation with Tom Mihaljevic GMP 15, CEO, Cleveland Clinic 

Cleveland Clinic, a non-profit academic medical center, provides clinical and hospital care and is a leader in research, education and health information. Cleveland Clinic has pioneered many medical breakthroughs including coronary artery bypass surgery and the first face transplant in the United States.  U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.

Tom Mihaljevic, MD, as CEO & President of Cleveland Clinic, is leading an $8 billion healthcare system that includes a main campus in Cleveland, 10 regional hospitals, 18 family health centers and facilities in Florida, Nevada, Toronto, Abu Dhabi and London. From 2010 to 2015, Dr. Mihaljevic was chief of staff and chairman of the Heart, Vascular & Thoracic Institute in Abu Dhabi. He joined Cleveland Clinic in 2004 as a surgeon in the Department of Thoracic and Cardiovascular Surgery. Prior to joining  the Clinic Tom was director of the Cardiac Surgery Research Laboratory at Brigham and Women’s, held a seven-year academic appointment to Harvard Medical School as a Clincal Fellow and was assistant professor of surgery at Harvard Medical School. He earned his medical degree from University of Zagreb,  trained in cardiac surgery at the University of Zurich and  in 2013 completed the GMP Exec. Ed. Program at HBS. His career has focused on minimally invasive approaches to a variety of cardiac issues and in 2005 he received a patent for a novel system for minimally invasive cardiac surgery.

Please plan to join us for this unique opportunity!

GOJO in the Pandemic, a conversation with Carey Jaros ’05, CEO, GOJO Industries

Join HBS NEO for a conversation with Carey Jaros ’05, CEO, GOJO Industries: “GOJO in the Pandemic”

Akron-based GOJO Industries, as much as any company in the world, is at the center of keeping all of us safe during the pandemic. GOJO’s purpose is Saving Lives and Making Life Better Through Well-Being Solutions.

Please join us for a moderated discussion and come prepared with questions as we hear how Carey and the rest of the GOJO team faced unprecedented, seemingly infinite demand, for PURELL®, their core product.

Carey Jaros was promoted to the position of President/CEO after three years as GOJO’s chief strategy officer. Before GOJO, Carey was president of Walnut Ridge Strategic Management Co., vice president at Cleveland-based Dealer Tire, and spent more than 10 years at Boston-based consulting firm Bain & Co. Carey graduated from Laurel School, Brown University and HBS. She and her husband, also a Class of ‘05 HBS alum, have three daughters and live in Shaker Heights.

Conversation with Mark DeLuzio: “FLATLINED: Why Lean Transformations Fail”

Join HBS NEO for a conversation with Mark DeLuzio, CMA, CPIM – President and CEO – Lean Horizons Consulting, LLC: “FLATLINED: Why Lean Transformations Fail”

About the presenter: Mark DeLuzio is founder and Chief Executive Officer of Lean Horizons Consulting, LLC  He is a former  Vice President of Danaher Business System (DBS) for Danaher Corporation , where he was the principal architect of DBS, deploying it on a global basis. Mark was selected by Danaher to be on the first study mission to Japan, studying under the original developers of the Toyota Production System. DBS has been credited by Wall Street as a key element to Danaher’s success.  Danaher has been recognized as the leading implementer of Lean globally and has been rated as the 3rd most profitable US stock over the last 30 years. Mark is also credited with developing the first Lean Accounting process in the United States for Danaher’s Jake Brake Division.  He is recognized as a pioneer in this area and is known as one of the “Fab 5” in the Lean Accounting community.

Mr. DeLuzio in 2007 was inducted as a Life Member of the Shingo Prize Academy (Lean Hall of Fame) for his lifetime contribution to “Excellence in Manufacturing.”

Having had two sons who fought in combat in the Middle East, Mark unfortunately became a Gold Star Father in 2010 when his son Steven (age 25) was killed in action fighting in Afghanistan.  Carrying on both of his sons’ contributions to our country, Mark was inspired to help Veterans (at no fee) wishing to start a business or needing career advice.  His organization is called B.R.A.V.E. (Business Reviews and Advisors to Veteran Entrepreneurs).  www.4thebrave.org

Through his B.R.A.V.E. organization, Mark has co-produced  “On the Hill”  which addresses the topic of Veteran suicide and Veteran PTSD.

Mr. DeLuzio is an alum of Central Connecticut State University, earned an MBA from the  University of Hartford,  is currently pursuing his Ph.D.  And has authored two books—”Turn Waste into Wealth” and  “Flatlined—Why Companies Fail at Lean and What to do About it.”

Global Networking Night 2020 featuring a Platform Beer tasting

Join HBS NEO for the annual Global Networking Night featuring a beer tasting from Platform Beer Co.

Registration for this event is now closed. Contact admin@hbs-neo.org with questions. 

Northeast Ohio’s Startup Environment in 2020 and Beyond

Join HBS NEO for a conversation with:

  • Clay Rankin ‘78—Founder, North Coast Ventures; Board, Angel Capital Association
  • Andrew Konya—CEO, Remesh
  • Todd Federman—Managing Director, North Coast Ventures
  • Daniel Luketic—Director, North Coast Ventures

Over the past decade, the Northeast Ohio startup community has seen many success stories including TOA Technologies being acquired by Oracle, Explorys being acquired by IBM, Scout RFP being acquired by Workday, Overdrive being acquired by Rakuten, and more.

North Coast Ventures (NCV) is comprised of nearly 300 Northeast Ohio based investors, entrepreneurs, and business leaders who are committed to driving superior returns by accelerating early stage ventures. NCV focuses its
investments in highly scalable, seed stage, business-to-business, software-as-a-service ventures focused on solving big problems where:

  • North Coast’s membership and network can provide significant value to help achieve superior outcomes
  • North Coast’s access to industry expertise can drive added value and lead to market-making reference customers NCV and its member investors have deployed over $60M into 59 companies.

Successful exits (sales to strategic acquirers or private equity firms) Include Assurex, Ahalogy, zNode, Collaborent (Sourcing Alliance), and OnShift. Successful companies where we continue to maintain an ownership position include Remesh, Proformex, ScriptDrop, AmpliFund, Navistone, EmployStream, Complion and Stelytics.


Zoom information will be emailed in advance of the event.

A Conversation with Fred Brown, MBA‘85: Defeating Covid19

We are pleased to welcome fellow alum Fred Brown, MBA‘85, as Medicinal Biochemist for a discussion on “Defeating Covid19.”

Fellow HBS alum Fred Brown, MBA ’85, is a medicinal biochemist who has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic and 6 vaccine products. Collectively, these products save the lives of over 5.6 million people annually and generated over $35B of revenue in 2020.

Fred comes to the fight against the COVID-19 virus from a forty-year career developing pharmaceutical solutions to fight infectious diseases and suppressing epidemics including HIV, H5N1, Ebola, Zika, measles and malaria. His extensive experience managing past pandemics is accelerating and supporting personal, business and government responses to COVID-19 around the world.

Fred has assisted 17 U.S. state governments, 5 national governments, 2 NGO’s, various agencies and selected mayors with their COVID response during this outbreak.

You will not want to miss this 90-minute, in-depth presentation to deepen your understanding of this life-and-death crisis which affects our families, our businesses, our country, and the entire world.  It might even save your life.

 Fred’s presentation will include:

  • The latest regarding what we know regarding treatment strategies, transmission, immunity, testing, and economic impact
  • Efficacy and factors for non-pharmacological interventions
  • Performance of the U.S. vs. other nations
  • Forecasts for the progression of the pandemic through this winter and beyond
  • Updates on WARP speed vaccines:  development, efficacy, timelines, politics and challenges
  • Economics:  impacts by sector, best-tools for government intervention, and forecast

Link to the virtual platform will be sent to you prior to the event.